Nonalcoholic Steatohepatitis
Pegozafermin Shows Promise for Treating MASH
The new drug pegozafermin could offer a promising treatment for patients with metabolic ...
DECEMBER 6, 2023
Societies Change Term for Fatty Liver To Focus on Steatosis
After years of discussion and review, an international working group has announced recently that they will refer to ...
AUGUST 28, 2023
Anthony Lembo, MD, Highlights Abstracts from DDW 2023
Eosinophilic esophagitis, nonalcoholic steatohepatitis and more! Gastro Endo News sat down with Anthony Lembo, ...
JUNE 1, 2023
Novel Liquid Biopsy Found More Reliable For Diagnosing NASH Than Current Strategies
A novel liquid biopsy has proven to be accurate, sensitive and specific in diagnosing the presence and severity of ...
DECEMBER 1, 2022
Metabolic Bariatric Surgery Yields Weight Loss, Liver Improvements in Obese Adolescents
WASHINGTON—Metabolic bariatric surgery can yield significant improvements in nonalcoholic steatohepatitis ...
NOVEMBER 11, 2022
Expert Picks From EASL 2022: Liver Disease
Seven noteworthy abstracts from EASL 2022 on topics including nonalcoholic steatohepatitis-related cirrhosis, ...
NOVEMBER 8, 2022
Nonalcoholic Steatohepatitis
The management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) involves ...
OCTOBER 12, 2022
